Friedreich Ataxia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are aged 16 years or older
- You have been diagnosed with Friedreich's ataxia, confirmed through genetic testing
- You have been receiving omaveloxolone treatment between February 2024 and May 2025, and have been on this treatment for at least 6 months
Who may not be able to join:
- You permanently stopped taking omaveloxolone before completing 6 months of treatment
- You did not complete a specific swallowing questionnaire (called the Sydney Swallow Questionnaire) both at the start of treatment and after 6 months of treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 04 92 03 96 55
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluate the progression of dysphagia after 6 months of treatment with Omaveloxolone.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.